STAT4 and hepatocellular carcinoma: Interestingly, 23 GG genotype carriers had higher expression levels than 19 TG and 23 TT genotype carriers (P < 0.05, Fig. 1E) in patients with HCC, while the polymorphism had no effect on STAT4 content in the control group (P > 0.05, Fig. 1F).